Laxmi Dental Limited , a leading integrated dental solutions provider, has reported robust financial results for the second quarter of fiscal year 2026, demonstrating resilience in a challenging global economic landscape.

Key Financial Highlights

• Revenue surged by 26.5% year-on-year to Rs. 72.00 crores
• EBITDA margin maintained at a healthy 15.3%
• PAT margin stood at 11.8%
• PBT (before JV profit) increased by 93.2% YoY

Segment-wise Performance

Strong Growth in Core Business

Laxmi Dental's dental laboratory business, excluding scanner sales, grew by an impressive 29.9% year-on-year. The domestic lab business saw a 23.2% increase, while the international lab business surged by 39.2%, despite facing US tariff pressures that impacted margins by 90 basis points.

Digital Dentistry Push

The company's strategic focus on digital dentistry is evident in its scanner sales, which grew by 94.7% year-on-year. This aligns with Laxmi Dental's goal of increasing digital penetration to over 90% among its associated dentists.

Aligner Solutions and Vedia Performance

The aligner solutions segment, including Bizdent and Vedia, reported a 12.3% year-on-year growth. Notably, Vedia, which produces raw materials and machines for aligner manufacturing, delivered a strong 29.9% growth, showcasing the increasing global demand for its Taglus brand.

Management Commentary

Sameer Merchant, Managing Director and CEO, stated, "We continue to deliver a robust performance in Q2 FY26, achieving our strongest ever quarterly sale for the second time in a row. Our impressive revenue growth amid a volatile global economic landscape highlights our business model's resilience and the effectiveness of our strategic approach."

Future Outlook

The management remains confident in maintaining its strong growth trajectory and meeting the full-year revenue guidance while preserving a healthy margin profile. The company aims for 20-25% revenue growth and 13-15% PAT margins for FY26, subject to ongoing global uncertainties.

Laxmi Dental is focusing on expanding its global presence, particularly in the pediatric dental solutions segment, with regulatory approvals progressing as planned. The company expects to receive CE certification in Q4, potentially opening up access to about 40 countries.

Investor Meeting

The company has scheduled a 1x1 meeting with investors, organized by Elara Capital, on November 25, 2025, in Mumbai, indicating ongoing engagement with the investment community.

As Laxmi Dental continues to innovate and expand its digital dentistry offerings, the company appears well-positioned to capitalize on the growing opportunities within the dynamic dental industry, both domestically and internationally.

Laxmi Dental Limited , a prominent player in the dental products industry, has announced ambitious growth projections for the fiscal year 2026 (FY26). The company expects to achieve a significant revenue growth of 20-25% while maintaining robust Profit After Tax (PAT) margins between 13-15%.

H1 FY26 Performance and Future Outlook

Laxmi Dental has reported a solid performance for the first half of FY26, with PAT margins reaching 12.2%. The company's management expressed confidence that the second half of the fiscal year is poised to outperform H1, potentially pushing the full-year margins into the projected 13-15% range.

Management's Perspective

The company's leadership remains optimistic about maintaining strong growth momentum and meeting its full-year revenue guidance. This positive outlook is tempered with a note of caution regarding global uncertainties that could impact the business landscape.

Long-term Profitability Goals

In addition to its near-term projections, Laxmi Dental has set an ambitious long-term target for its EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) margin. The company aims to achieve and maintain an EBITDA margin of at least 20%, highlighting its commitment to sustainable profitability and operational efficiency.

Recent Financial Performance

The company's consolidated financial results for the quarter ended September 30, 2025, offer insights into its current financial health:

These figures demonstrate Laxmi Dental's strong financial position and provide context for its optimistic future projections.

Segment-wise Performance

Laxmi Dental operates across three main business segments:

1. Laboratory Business: Includes dental prosthesis such as metal-free crowns & bridges, and Porcelain Fused to Metal (PFM) crowns and bridges.
2. Aligners Business: Comprises dental aligners, retainers, raw materials for aligners, sport guards, night guards, and sleep apnea devices.
3. Other Business: Encompasses dental distribution products used in dental laboratories, dental clinical services, and dental educational courses.

The company's diverse product portfolio positions it well to capitalize on various segments of the dental market.

Strategic Investments

Laxmi Dental has made strategic investments to support its growth plans:

• Invested in IDBG AI Dent Global Private Limited, acquiring a 49% stake through equity shares and compulsory convertible preference shares.
• Increased investment in its USA subsidiary, Laxmi Dental Lab USA INC, to support working capital needs and business growth.
• Acquired additional shares in its wholly-owned subsidiary, Bizdent Devices Private Limited, through a rights issue.

These investments underscore the company's commitment to expanding its market presence and technological capabilities.

Conclusion

Laxmi Dental Limited's projected revenue growth of 20-25% and targeted PAT margins of 13-15% for FY26 reflect the company's strong position in the dental products market. With a solid H1 FY26 performance, strategic investments, and a diversified product portfolio, the company appears well-positioned to achieve its ambitious targets. However, as noted by management, global economic uncertainties may present challenges that will require careful navigation in the coming months.